Cargando…

Anesthetic management of laparoscopy-assisted total proctocolectomy in a cardiac sarcoidosis patient with a cardiac resynchronization therapy-defibrillator: a case report

BACKGROUND: Cardiac sarcoidosis (CS) causes severe conduction abnormalities and arrhythmias. CS patients are increasingly being treated with cardiac resynchronization therapy-defibrillators (CRT-Ds). For the first time, we report the anesthetic management of a CS patient with a CRT-D. CASE PRESENTAT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kammura, Yutaro, Fujita, Ai, Karashima, Yuji, Nakayama, Shoko, Shirozu, Kazuhiro, Kandabashi, Tadashi, Yamaura, Ken
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275943/ https://www.ncbi.nlm.nih.gov/pubmed/32506211 http://dx.doi.org/10.1186/s40981-020-00350-7

Ejemplares similares

Anesthetic management of pheochromocytoma and paraganglioma for patients with Fontan circulation: a case series
por: Tanaka, Yuto, et al.
Publicado: (2023)

Anesthetic management of hepatectomy for the patient with Fontan circulation: a case series
por: Sumie, Makoto, et al.
Publicado: (2022)

Benefit of magnetic resonance–conditional cardiac resynchronization therapy defibrillator: A case of cardiac sarcoidosis–involved cervical extradural lesion
por: Kawakami, Hiroshi, et al.
Publicado: (2015)

One Indication for an Extravascular Cardiac Resynchronization Therapy Defibrillator: Lessons from a Combination Therapy Case with Epicardial Cardiac Resynchronization Therapy and a Subcutaneous Implantable Cardioverter Defibrillator
por: Ishii, Natsuko, et al.
Publicado: (2021)

Cardiac resynchronization therapy defibrillators in patients with permanent atrial fibrillation
por: Rapacciuolo, Antonio, et al.
Publicado: (2021)

Cardiac resynchronization therapy with or without defibrillator in patients with heart failure
por: Schrage, Benedikt, et al.
Publicado: (2021)

Cardiac Sarcoidosis: Indications for Implantable Cardioverter-Defibrillator Therapy
por: Yalta, Kenan, et al.
Publicado: (2022)

Manual vs. automatic capture management in implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators
por: Murgatroyd, Francis D., et al.
Publicado: (2010)

Management of sudden cardiac death in cardiac sarcoidosis using the wearable cardioverter defibrillator
por: Skowasch, Dirk, et al.
Publicado: (2018)

MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy): cardiac resynchronization therapy towards early management of heart failure
por: Breithardt, Günter
Publicado: (2009)

Economic impact of longer battery life of cardiac resynchronization therapy defibrillators in Sweden
por: Gadler, Fredrik, et al.
Publicado: (2016)

Prevalence of Echocardiographic Features Suggesting Cardiac Sarcoidosis in Patients With Pacemaker or Implantable Cardiac Defibrillator
por: Sun, Byung Joo, et al.
Publicado: (2011)

Cerebral infarction detected after laparoscopic partial hepatectomy: case report
por: Kobayashi, Atsushi, et al.
Publicado: (2019)

Prevention of sudden cardiac death by the wearable cardioverter defibrillator in a young patient with cardiac sarcoidosis
por: Andrié, René, et al.
Publicado: (2017)

Cardiac Resynchronization Therapy Defibrillator Treatment in a Child with Heart Failure and Ventricular Arrhythmia
por: Kim, Hak Ju, et al.
Publicado: (2016)

Loss of cardiac resynchronization therapy in a patient with a biventricular implantable cardioverter-defibrillator
por: Alasti, Mohammad, et al.
Publicado: (2017)

Cardiac resynchronization therapy pacemakers versus defibrillators in older non-ischemic cardiomyopathy patients
por: Wang, Yanting, et al.
Publicado: (2018)

Implantation of a cardiac resynchronization therapy and defibrillation system using a robotic approach
por: Amraoui, Sana, et al.
Publicado: (2015)

Renal function and the long‐term clinical outcomes of cardiac resynchronization therapy with or without defibrillation
por: Leyva, Francisco, et al.
Publicado: (2019)

Survival of patients undergoing cardiac resynchronization therapy with or without defibrillator: the RESET-CRT project
por: Hadwiger, Moritz, et al.
Publicado: (2022)

An updated meta-analysis of cardiac resynchronization therapy with or without defibrillation in patients with nonischemic cardiomyopathy
por: Liu, Fuwei, et al.
Publicado: (2023)

Economic analysis of remote monitoring in patients with implantable cardioverter defibrillators or cardiac resynchronization therapy defibrillators in the Trento area, Italy
por: Marini, Massimiliano, et al.
Publicado: (2023)

The economic impact of remote control in patients with implantable cardioverter defibrillators or cardiac resynchronization therapy defibrillators: single center experience
por: Marini, M, et al.
Publicado: (2023)

Intubation Technique in a Patient with Tracheobronchopathia Osteochondroplastica
por: Takamori, Ryoko, et al.
Publicado: (2021)

Treatment of trigeminal and glossopharyngeal neuralgia in an adolescent: a case report
por: Maeda, Aiko, et al.
Publicado: (2021)

1-kHz high-frequency spinal cord stimulation alleviates chronic refractory pain after spinal cord injury: a case report
por: Yamada, Chiaki, et al.
Publicado: (2021)

Cardiac electrophysiological alterations and clinical response in cardiac resynchronization therapy with a defibrillator treated patients affected by metabolic syndrome
por: Sardu, Celestino, et al.
Publicado: (2017)

The importance of leadless pacemaker positioning in relation to subcutaneous implantable cardioverter-defibrillator sensing in completely leadless cardiac resynchronization and defibrillation systems
por: Elliott, Mark K., et al.
Publicado: (2021)

Clinical Diagnosis of Cardiac Sarcoidosis Improves Treatment Effectiveness and Unmasks Isolated Cardiac Sarcoidosis
por: Yamamoto, Kazuhiro
Publicado: (2021)

Outcomes after transvenous defibrillator implantation in cardiac sarcoidosis: A systematic review
por: Taha, Ahmed, et al.
Publicado: (2022)

Reply to Yalta and Yetkin—Cardiac Sarcoidosis: Indications for Implantable Cardioverter-Defibrillator Therapy
por: Duffett, Stephen A., et al.
Publicado: (2022)

The prognosis of implantable defibrillator patients treated with cardiac resynchronization therapy: comorbidity burden as predictor of mortality
por: Theuns, Dominic A.M.J., et al.
Publicado: (2011)

Long-term clinical outcomes of cardiac resynchronization therapy with or without defibrillation: impact of the aetiology of cardiomyopathy
por: Leyva, Francisco, et al.
Publicado: (2018)

Mid-term feasibility and safety of downgrade procedure from defibrillator to pacemaker with cardiac resynchronization therapy
por: Ogano, Michio, et al.
Publicado: (2018)

Clinical outcomes of cardiac resynchronization therapy with and without a defibrillator in elderly patients with heart failure
por: Christie, Simon, et al.
Publicado: (2018)

Implantable cardioverter defibrillator and cardiac resynchronization therapy use in New Zealand (ANZACS‐QI 33)
por: Foo, Fang Shawn, et al.
Publicado: (2019)

Association Between Subcutaneous Implantable Cardioverter Defibrillator Preimplantation Screening and the Response to Cardiac Resynchronization Therapy
por: Jing, Ran, et al.
Publicado: (2020)

Right ventricular dominant myocarditis requiring cardiac resynchronization therapy‐defibrillator: a case report
por: Sato, Takanori, et al.
Publicado: (2021)

Magnetic resonance imaging in a patient with cardiac resynchronization therapy‐defibrillator and two abandoned leads
por: Lüsebrink, Enzo, et al.
Publicado: (2022)

Arrhythmic and mortality outcomes in patients with dilated cardiomyopathy receiving cardiac resynchronization therapy without defibrillator
por: Samy, Mohammed, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_24m1mnj37gdm0gjvl6bena4j4n